Hinge Health holder plans sale of 100,000 shares
A Rule 144 filing reports that an insider plans a potential sale of up to 100,000 HNGE common shares with an indicated $9.1 million market value.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Hinge Health, Inc. (HNGE) received a notice that Daniel Perez plans to sell up to 100,000 shares of common stock under Rule 144. The proposed sale is through Morgan Stanley Smith Barney LLC, with an indicated aggregate market value of $9,131,000 and NYSE as the listed exchange.
The shares relate to restricted stock units acquired from the issuer on May 21, 2025. The filing lists 62,468,721 shares outstanding of the same class of common stock, which is a baseline figure and not the amount being sold.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Units financial
aggregate market value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing disclose for HNGE?
What type of securities are involved in Daniel Perez’s Form 144 for HNGE?
AI-generated analysis. How Rhea-AI works. Not financial advice.